FDA Approved: CYSTADROPS — Original Application (RECORDATI RARE DISEASES, INC.)

View source ↗

Summary

FDA approves CYSTADROPS (cysteamine hydrochloride) from Recordati Rare Diseases for the treatment of corneal cystine crystal accumulation in patients with cysti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Drugs mentioned

• Cystadrops (mercaptamine hydrochloride)

Snippet

ORIG AP for CYSTADROPS (CYSTEAMINE HYDROCHLORIDE)